Vitamica is developing a rapid method for testing whether bacterial pathogens.
Vitamica was established in early 2018 as a spin-out company from the University of Bristol. Taking optical technology from the School of Physics, the new company is beginning its journey towards commercialisation of a rapid and novel diagnostic method that has high potential for use in antimicrobial susceptibility testing. With a growing IP portfolio and an active approach to identifying opportunities in healthcare, veterinary and pharma sectors, Vitamica fully intends to make its mark as another successful company to originate from the University of Bristol.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 5, 2018 | Seed | — | 1 | Wyvern Seed Fund | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Wyvern Seed Fund | Yes | Seed |